字号·· | 护眼
semafor

无国界医生组织敦促全球卫生官员扩大埃博拉疫苗可及范围MSF urges global health officials to widen Ebola vaccine access

点「原文对照」整页切到原文,或双击某段只看那段的原文。

格拉德尔·穆伊萨·蒙贝雷/路透社Gradel Muyisa Mumbere/Reuters

在有关一种现有埃博拉疫苗可能对一种其并非针对的毒株提供保护的报告传出后,全球卫生官员被敦促在刚果民主共和国扩大该疫苗的使用。本迪布焦型毒株目前尚无疫苗可用,已在刚果(金)迄今规模最大的疫情中导致5300多人死亡。医疗慈善机构无国界医生组织表示,应解除对默克公司研发、用于对抗此前一种埃博拉毒株的Ervebo疫苗的使用限制,以便让更多面临风险的人群,包括幼儿,能够接种。

Global health officials have been urged to widen the use of an existing Ebola vaccine in DR Congo following reports it may provide protection against a strain it was not designed to target. The Bundibugyo strain — for which there is currently no vaccine — has killed more than 5,300 people in the country’s largest-ever outbreak. Medical charity Doctors Without Borders said restrictions on using Ervebo, developed by Merck for use against a prior Ebola strain, should be lifted so more people at risk, including young children, can be vaccinated.

该慈善机构表示,刚果(金)申请了50万剂Ervebo疫苗,但仅获批释放7万剂。世界卫生组织建议将其用于对抗本迪布焦型毒株仅限于研究性使用,因为其效果仍未得到证实。无国界医生组织表示,此前接种过疫苗的人群中感染和死亡人数较少的早期观察结果,为扩大使用提供了依据。要从全球储备中释放更多剂量,需要世卫组织疫苗顾问的支持,他们将于下周开会。

The charity said DR Congo requested 500,000 doses of Ervebo, but only 70,000 were released. The World Health Organization recommends limiting its use against Bundibugyo to research studies because its effects remain unproven. Doctors Without Borders said early observations of fewer infections and deaths among previously vaccinated people justified wider use. A larger release from the global stockpile requires backing from the WHO’s vaccine advisers, who meet next week.

阅读媒体原文 ↗